Dermatologists say with education ‘number can be closer to zero’.

With the world now starting to reopen, and people finally being able to venture abroad without fear of being stranded or extensive travel restrictions, it is important to recognise the dangers of spending too much time in the sunshine – skin cancer.

And now, a new survey has shown that 1.71 per cent of the adult European population have reported having skin cancer, meaning some 7,304,000 Europeans are estimated to have the disease.

Presented at the European Academy of Dermatology and Venereology (EADV) Spring Symposium, the survey data shows that a mole check or skin cancer screening was the main reason for patients consulting a dermatologist over the past 12 months, with over a fifth (22.3 per cent) of appointments made with a skin specialist being to check a mole or lesion.

The findings from the EADV’s Burden of Skin Disease (BOSD) survey of more than 44,000 adults from 27 countries indicate the need for an “expansion in skin cancer education across Europe to help the population make safer skin choices,” according to leading dermatologists at the organisation.

This is despite skin cancer being the most preventable cancer since most cases are caused by damage from the sun’s ultraviolet rays.

“Skin cancer is part of the 40 per cent of cancers that are preventable and whose incidence we could considerably reduce if we provided more consistent and widespread education to the population,” says Professor Marie-Aleth Richard, Professor at the University Hospital of La Timone, Marseilles and the EADV Board Member leading the survey.

Of the people surveyed, 0.6 per cent reported a diagnosis of melanoma, the deadliest form of skin cancer. However, keratinocyte carcinomas, which include basel cell and squamous cell carcinomas, are by far the most widespread of all cancers and the most rapidly increasing with incidence expected to rise by over 40 per cent until 2040.

Professor Richards stated that the survey “demonstrates the need for action to be taken to prevent skin cancer, which has a good prognosis if caught early but is perceived by the population as a serious and life-threatening condition.”

“It underscores the need for improved understanding, education and awareness about skin cancer and implementing evidence-based interventions as part of Europe’s Beating Cancer Plan,” she added.

“This should be complementary to an adequate policy and regulatory framework to reduce the incidence of skin cancer and prevent it becoming a significant challenge to health systems.”

Skin cancer and Quality of Life

Almost half of people surveyed (46.6 per cent) who reported at least one skin cancer said they felt ‘moderately or extremely anxious and depressed’, with anxiety and fear about surgical scars, death and metastasis being the main reason for an alteration in their quality of life.

Whilst nearly half of patients said there was a negative impact on their personal life, almost three in five said they were impacted in their professional life. The biggest result was a change in working hours or altering professional activity but 22.6 per cent said they did not get a hoped-for job and 31.3 per cent refused a professional offer.

Dermatologists viewed as the experts on skin cancer

Dermatologists were recognised by over half of those surveyed as the experts on skin cancer, with 52.73 per cent saying they would trust a skin professional to treat them over a general practitioner or other health care professional, which Prof Richard said “demonstrated the important role dermatologists play in the diagnosis and treatment of skin cancers as well as the role they can play in prevention and education of the disease.”

The type of doctor consulted in the case of skin cancer varied by country, with the largest percentage of patients who called on a dermatologist in the first instance found in Italy (53 per cent), France (47.4 per cent) and Spain (44.8 per cent).

The lowest proportion reported was in the UK, where only 11.9 per cent of patients initially went to a dermatologist followed by Poland with 13.5 per cent. However, in almost half of the cases (45.7 per cent), the final diagnosis was predominantly made by a dermatologist.

“As recognised experts for the management of skin cancers, dermatologists must play a central role in public health strategies for beating cancer and in educating the general public, media, stakeholders and decision makers about skin diseases including cancer,” says Prof Alexander Stratigos, President of the EADV.

“These include promoting the protection of children and teenagers to reduce the risk of skin cancers developing in later life, implementing UV protection measures for outdoor workers and the regulation of sunbeds as medical devices, not consumer products,” he added.

“We are also calling for the improved registration of skin cancer cases across Europe to help us detect groups most at risk and help public health programmes priorities.

“The EADV is committed to its aim of advancing excellence in patient care and advocating on behalf of dermatology professionals and patients.”